Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.5.4, indicating the site was updated to a newer release.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.5.3, has been added to the history and the previous entry, v3.5.2, has been removed, updating the record of the page revisions.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedFooter now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check95 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 funding notice text was removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.